May 6, 2020 / By Chris Ciaccia | Fox News
As the coronavirus pandemic continues into its sixth month with no cure, the maker of the recently approved drug remdesivir said it is working with companies to expand its manufacturing “through at least 2022.”
In an open letter obtained by Fox News, Gilead Sciences said it is working with “leading chemical and pharmaceutical companies” to make sure remdesivir is available in Europe, Asia and the developing world.
“Gilead is in discussions with some of the world’s leading chemical and pharmaceutical manufacturing companies about their ability, under voluntary licenses, to produce remdesivir for Europe, Asia and the developing world through at least 2022,” the company wrote. “The company is also negotiating long-term voluntary licenses with several generic drugmakers in India and Pakistan to produce remdesivir for developing countries.”
